EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mutators can drive the evolution of multi-resistance to antibiotics

Danna R Gifford iD, Ernesto Berríos-Caro iD, Christine Joerres iD, Marc Suñé, Jessica H Forsyth, Anish Bhattacharyya, Tobias Galla, Christopher G Knight iD

PLOS Genetics · 2023

DOI: 10.1371/journal.pgen.1010791 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Genetics, 2023. Verfasst von Danna R Gifford und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, …. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Mutation Rate. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Wellcome Trust, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotic combination therapies are an approach used to counter the evolution of resistance; their purported benefit is they can stop the successive emergence of independent resistance mutations in the same genome. Here, we show that bacterial populations with ‘mutators’, organisms with defects in DNA repair, readily evolve resistance to combination antibiotic treatment when there is a delay in reaching inhibitory concentrations of antibiotic—under conditions where purely wild-type populations cannot. In populations of Escherichia coli subjected to combination treatment, we detected a diverse array of acquired mutations, including multiple alleles in the canonical targets of resistance for the two drugs, as well as mutations in multi-drug efflux pumps and genes involved in DNA replication and repair. Unexpectedly, mutators not only allowed multi-resistance to evolve under combination treatment where it was favoured, but also under single-drug treatments. Using simulations, we show that the increase in mutation rate of the two canonical resistance targets is sufficient to permit multi-resistance evolution in both single-drug and combination treatments. Under both conditions, the mutator allele swept to fixation through hitch-hiking with single-drug resistance, enabling subsequent resistance mutations to emerge. Ultimately, our results suggest that mutators may hinder the utility of combination therapy when mutators are present. Additionally, by raising the rates of genetic mutation, selection for multi-resistance may have the unwanted side-effect of increasing the potential to evolve resistance to future antibiotic treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsMutation RateMutationEscherichia coliBacteriaEvolution, Molecular

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
  • Department of Earth and Environmental Sciences, School of Natural Sciences, Faculty of Science and Engineering, The University of Manchester, Manchester, United Kingdom.
  • Department of Physics and Astronomy, School of Natural Sciences, Faculty of Science and Engineering, The University of Manchester, Manchester, United Kingdom.
  • Department of Evolutionary Theory, Max Planck Institute for Evolutionary Biology, Plön, Germany.
  • Department of Evolutionary Ecology and Genetics, Christian-Albrechts-University of Kiel, Kiel, Germany.
  • Instituto de Física Interdisciplinar y Sistemas Complejos, IFISC (CSIC-UIB), Campus Universitat Illes Balears, Palma de Mallorca, Spain.

ORCID-Profile: Danna R Gifford, Ernesto Berríos-Caro, Christine Joerres, Christopher G Knight

Förderung

  • Biotechnology and Biological Sciences Research Council
  • Wellcome Trust
  • Medical Research Council
  • UKRI Innovation/Rutherford Fund Fellowship
  • Academy of Medical Sciences
  • Postdoctoral Seed Award from Earth and Environmental Sciences, The University of Manchester
  • Swedish Research Council
  • The Maria de Maeztu program for Units of Excellence in R&D

Zitieren

APA

Gifford, D. R., Berríos-Caro, E., Joerres, C., Suñé, M., Forsyth, J. H., Bhattacharyya, A., Galla, T., & Knight, C. G. (2023). Mutators can drive the evolution of multi-resistance to antibiotics. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1010791

Vancouver

Gifford DR, Berríos-Caro E, Joerres C, Suñé M, Forsyth JH, Bhattacharyya A, et al. Mutators can drive the evolution of multi-resistance to antibiotics. PLOS Genetics. 2023. doi:10.1371/journal.pgen.1010791

BibTeX
@article{Gifford2023,
  author = {Gifford, Danna R and Berríos-Caro, Ernesto and Joerres, Christine and Suñé, Marc and Forsyth, Jessica H and Bhattacharyya, Anish and Galla, Tobias and Knight, Christopher G},
  title = {Mutators can drive the evolution of multi-resistance to antibiotics},
  journal = {PLOS Genetics},
  year = {2023},
  doi = {10.1371/journal.pgen.1010791}
}
Kostenlos starten →